USD 3.55 billion
Clinical Trial Supplies Market Size, Share, Growth Analysis, By Phase(Phase I, Phase II, Phase III, Phase IV), By Service(Manufacturing, Storage & Retention, Logistics and Distribution, Packaging), By Therapeutic Area(Oncology, immunology, cardiology, genetic diseases), By Type(Small molecules, biological drugs, medical devices), By End-user(Pharmaceutical and Biotechnology Companies, Contract Research Organisations (CRO's), Medical Device Companies), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2077 |
Region:
Global |
Published Date: August, 2024
Pages:
219
|Tables:
90
|Figures:
76
Clinical Trial Supplies Market Insights
The Global Clinical Trial Supplies Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.9 billion in 2023 to USD 4.50 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).
Clinical trial supplies are becoming increasingly important due to the rising expenses associated with drug research. Furthermore, ongoing improvements must be made to the clinical trial supplies strategy and the implementation of stricter handling standards for a particular class of biopharmaceutical product that is beginning clinical trials. Key drivers driving the growth of the global clinical trials supplies market include rising R&D spending in biopharmaceutical and pharmaceutical businesses, an increase in the number of clinical trials, and higher drug development expenses in developed nations. Nonetheless, throughout the projected years, the market growth is anticipated to be constrained by the growing expenses associated with drug research and clinical trials, as well as the difficulties posed by the adverse effects of the coronavirus.
The rapidly rising prevalence of chronic illnesses worldwide is probably going to continue to be a trend in the global clinical trial supplies market. Contract manufacturers and service providers offering clinical trial outsourcing give pharmaceutical drug manufacturers enough time to create new medication formulations, stay in regular and continuous contact with other pharmaceutical businesses, avoid dangers, and achieve other benefits. Pharmaceutical and biopharmaceutical firms can obtain logistics and distribution services from organizations like Fisher Clinical Services, Inc., PAREXEL International, and Piramal Pharma Solutions. Therefore, the market size rise for clinical trial supplies can be attributed to the previously mentioned factors.
US Clinical Trial Supplies Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Phase III
Fastest Growth
Phase IV
Growth Rate
9.9% CAGR
Global Clinical Trial Supplies Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Clinical Trial Supplies Market Segmental Analysis
The Global Clinical Trial Supplies market is segmented by phase, application, therapeutic use, type, end user, service and region. Based on phase, the market is segmented into Phase I, Phase II, Phase III, and Phase IV. Based on application, the market is segmented into pharmaceutical and biopharmaceutical, and contract research organizations (CROs). Based on therapeutic use, market is segmented into Oncology, immunology, cardiology, genetic diseases, Cardiovascular, Infectious disease, Metabolic disorders, Others. Based on service market is segmented into Manufacturing, Storage & retention, logistics and distribution, packaging, labelling and blinding, comparator sourcing and others. Based on type market is segmented into, Small molecules, biological drugs, medical devices.Based on end-user, it is segmented as Pharmaceutical and Biotechnology Companies, Contract Research Organisations (CRO's), Medical Device Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Clinical Trial Supplies Market Analysis by Type
As per categorization by type, the market is classified as small-molecules, biologic drugs and medical devices. Among these, small molecules earned the largest share and continue to dominate the market. Innovation in the small-molecules type of the global clinical trial supplies market is driven by their critical role in drug development, targeting a wide range of therapeutic areas, including oncology and cardiovascular diseases. Small molecules' ease of synthesis, oral bioavailability, and established manufacturing processes contribute to their market dominance. They are essential in early-stage clinical trials, with robust pipelines for new drugs further fueling their demand, making them the preferred choice in clinical research and trials.
Out of all the segments in the global clinical trial supplies market, biologic drugs are set to grow the most for various reasons. The rising incidence of chronic and complicated disorders along with developments in technologies are the factors causing the need for new therapies that can be offered by biology. Furthermore, the increasing focus on ‘one-size-fits’ therapies and targeted treatments also makes them interesting. Furthermore, as the regulations are changing to promote the development and approval of biologics, more companies are turning their focus to biologics which is in turn driving the expansion of clinical trial supplies related to this area.
Clinical Trial Supplies Market Analysis by End User
Pharmaceutical and biotechnology companies are at the forefront of innovation in the global clinical trial supplies market, driving advancements in personalized medicine, biologics, and gene therapies. Their extensive research and development pipelines, supported by large-scale investments, enable faster drug development and clinical trials. These companies dominate the market due to their financial capabilities, access to cutting-edge technologies, and collaborations with academic institutions and contract research organizations (CROs). Additionally, their expertise in regulatory compliance and supply chain management ensures smooth trial operations, positioning them as key players in meeting the increasing demand for clinical trial supplies worldwide.
It is expected that CROs or Contract Research Organizations will be the fastest growing segment in the global clinical trial supplies market owing to the rising tendency of pharmaceutical and biotechnology companies to outsource their operations. Since these organizations try to cut costs and improve their efficiency, they will turn to CROs for expertise in management of the trial, logistics and regulatory issues. In addition, the increasing sophistication of clinical trials, especially for biologics and tailored medicine, is also fuelling the need for such services. Ease of use and scalability of operations are why they are an important aspect of contemporary clinical research.
Global Clinical Trial Supplies Market By Type (%)
To get detailed analysis on other segments, Request For Free Sample Report
Clinical Trial Supplies Market Regional Insights
North America dominates the global clinical trial supplies market due to its robust pharmaceutical and biotechnology sectors, which are characterized by high R&D investments and a vast pipeline of innovative therapies. Many top Contract Research Organizations (CROs) can also be found in the region alongside the existing regulatory systems that support quick trial management and product approval. Growing recruitment is another advantage that North America's robust healthcare system and wide patient pool avail, which positively affects the timelines and the results of the clinical trials. In addition to the presence of large pharmaceutical firms and great emphasis on developing new biopharmaceuticals, clinical trial supplies in North America are in very high demand, making this region very competitive in the markets.
The Asia-Pacific region is the fastest-growing market for clinical trial supplies, driven by increasing investments in pharmaceutical research and a growing emphasis on drug development. The demand for such services is further driven by the increase in the rate of chronic diseases and the large and varied patient population that facilitates the recruitment for clinical trials. Further, a number of governments are putting in place positive policies and regulations, which include tax holidays, in order to lure investors to set up CROs and factories. In addition, the operational cost advantages of the region in conjunction with improved clinical trial practices and technologies make the conduct of clinical trials in Asia Pacific a more attractive option, thereby driving the growth of the market even further.
Global Clinical Trial Supplies Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Clinical Trial Supplies Market Dynamics
Clinical Trial Supplies Market Drivers
Increasing Demand for Personalized Medicine
- One of the most important factors impacting the global clinical trial supplies market is the increasing focus on precision medicine. With the treatment becoming specific to individual patients, there is a rise in the need for new treatment options and biologic medicines. This transformation warrants the expansion of specialized clinical trial supplies to address the complexities of the clinical trial designs as well as the patient stratification.
Rising Outsourcing of Clinical Trials
- The increasing trend of outsourcing clinical trials to Contract Research Organizations (CROs) is another key driver. Pharmaceutical and biotechnology companies aim to increase their efficiency and cut their costs by utilizing the expertise of CROs. This trend inclined the demand for clinical trial supplies as CROs have to source reliable and creative materials to run various clinical programs successfully.
Clinical Trial Supplies Market Restraints
Supply Chain Disruptions
- The global clinical trial supplies market is mainly affected by global supply chain disruptions. Political conflicts, natural calamities, and even diseases can affect the supply of materials and transportation. Such interruptions may cause postponements in beginning the trials and escalate operational costs, hence, impacting the efficiency of the activities relating to clinical research.
Complexity of Trial Designs
- As the designs of clinical trials get more complex–specifically, with the case of combination or multiple drug studies–it presents a huge obstacle. This is often due to the need for special materials and individualized methods, which causes the trials to be more costly. Such requirements can create challenges in operations and increase expenditure making the sponsor hesitant to implement new trials and even new supplies.
Request Free Customization of this report to help us to meet your business objectives.
Clinical Trial Supplies Market Competitive Landscape
The global clinical trial supplies market is witnessing competition from a blend of traditional drug manufacturers, Contract research organizations (CROs) and clinical materials suppliers. Such able companies consist of Catalent, Thermo Fisher Scientific, Almac Group, PRA Health Sciences among others. They use modern day technologies and form strategies to create partnerships to improve efficiency and process supply chains to keep up with increases in throughput of clinical trials and changes in drug development. The level of competition is also high as there is a war on quality, speed and adherence to regulations among the players.
Clinical Trial Supplies Market Top Player’s Company Profiles
- Catalent, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Sharp Packaging Services (US)
- CordenPharma (Austria)
- Almac Group (UK)
- PCI Pharma Services (US)
- Eurofins Scientific (Luxembourg)
- ICON plc (Ireland)
- Biocair International Ltd (UK)
- DHL (Germany)
- Myoderm (US)
- Ancillare LP (US)
- Intertek Group plc (UK)
- KLIFO A/S (Denmark)
- N-SIDE (Belgium)
- Sharp Clinical Services (US)
- Catalent Pharma Solutions (US)
- Woodfield Distribution, LLC (US)
- Avantor, Inc. (US)
- Worldwide Clinical Trials, Inc. (US)
Clinical Trial Supplies Market Recent Developments
- In October 2023, Almac Group announced a partnership with a leading biotech firm to develop a novel drug delivery system for clinical trials. This collaboration aims to streamline the clinical supply chain and improve patient adherence. Almac’s expertise in drug packaging and logistics will enhance the efficiency of the trial process.
- In September 2023, Catalent brought to light a groundbreaking temperature management shipping solution for clinical supplies during trials. This presents a significant solution to the problems exhibited by the cold chain during transport of temperature sensitive items. The solution seeks to enhance reliability and compliance with clinical trials in order to promote patient and data safety.
- In August 2023, Thermo Fisher Scientific publicized further development of its clinical trials supply services with the establishment of a new hi-tech packing plant in the USA. This facility’s goal is to improve operational efficiency and extend the scope of clinical trial material to support quicker turn-around times for sponsors.
Clinical Trial Supplies Key Market Trends
- Rise of Decentralized Clinical Trials: Due to the ongoing technology revolution, there has been an emergence of the shift to virtual studies and remote patient monitoring in the global clinical trial supplies market. Such widening of the participant base and inclusion lower the expenses involved as well as speeding up the process of carrying out the trials, which in turn changes the conventional trials carried out in clinical research for the better.
- Increased Focus on Cold Chain Logistics: There is an increasing focus on the improved and advanced cold chain logistics to protect the integrity of temperature sensitive clinical trial materials. With the rise of biologic and personalized medicine, companies are able to spend more on more advanced packaging and transportation solutions to increase compliance and safety but also meet the rigorous demands of contemporary clinical trials.
Clinical Trial Supplies Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, in conclusion, the global clinical trial supplies market is poised for significant growth driven by factors such as increasing R&D expenditures, a rise in clinical trials, and the urgent need for innovative treatments. While small molecules dominate due to established processes, biologic drugs are emerging rapidly, reflecting advancements in biotechnology.
Cost-effective management of clinical trials has led to the increasing adoption of Clinical Research Organizations (CROs) by biopharmaceutical and biotechnology companies to an extent. Nonetheless, factors such as interrupted supply chain and intricate trial designs can impede the growth of the market. As certain trends, for instance, virtual trials and better cold chain infrastructures mature, the sector will adapt and flourish.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 2.1 billion |
| Market size value in 2031 | USD 4.50 billion |
| Growth Rate | 6.5% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Clinical Trial Supplies Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Clinical Trial Supplies Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Clinical Trial Supplies Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Clinical Trial Supplies Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Clinical Trial Supplies Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Clinical Trial Supplies Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
